Zepp Health (ZEPP) Cash & Equivalents (2015 - 2025)

Zepp Health's Cash & Equivalents history runs 11 years deep, the most recent figure standing at $57.0 million for Q4 2025.

• In Q4 2025, Cash & Equivalents fell 37.36% year-over-year to $57.0 million; the TTM figure through Dec 2025 stood at $57.0 million (down 37.36% YoY), while the FY2025 annual figure was $57.0 million, down 37.36% from the prior year.
• Cash & Equivalents was $57.0 million for Q4 2025 at Zepp Health, down from $61.7 billion in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $131809.1 billion in Q4 2023 to a low of $76429.0 in Q1 2025.
• Historically, Cash & Equivalents has averaged $6658.3 billion across 5 years, with a median of $58.6 billion in 2025.
• The sharpest annual moves came in 2023 and 2025: Cash & Equivalents surged 105731351.96% in 2023, then slumped 100.0% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $229.7 million in 2021, then slumped by 45.72% to $124.7 million in 2022, then jumped by 105731351.96% to $131809.1 billion in 2023, then plunged by 100.0% to $91.1 million in 2024, then slumped by 37.36% to $57.0 million in 2025.
• The last three Cash & Equivalents figures came in at $57.0 million (Q4 2025), $61.7 billion (Q3 2025), and $55.4 billion (Q2 2025), per Business Quant data.